A+ A A-

Step 1.

Browse our selection of high quality generic AIDS medication and add it to your cart.


Step 2.

Pay for your order using VISA or MasterCard using our secure checkout area.


Step 3.

Send us your prescription, and the release form. We provide a tracking number when your order has shipped.


HIV & Thromboembolic Disease

Thromboembolic disease occurs when a blood clot, or a thrombus, forms in a blood vessel and travels through the bloodstream. The blood clot can then plug other vessels that lead to important organs such as the lungs, kidneys, gastrointestinal tract, legs and brain. Since HIV patients have started living to old age, doctors have discovered a link between HIV and abnormal blood clotting, which is also known as hypercoagulability. For this reason, people living with HIV may be more prone to thromboembolic disease than the general population.

Prevalence of Thromboembolic Disease in People Living With HIV

Thromboembolic disease often occurs when a patient is healing from a traumatic injury or surgery; however, some HIV patients develop abnormal blood clots when they otherwise seem healthy. The underlying reason for this is unknown, but researchers have identified a few abnormalities in HIV patients' blood that heighten the risk of blood clotting such as high levels of adhesion molecules and deficiencies in certain proteins.

Preventing Thromboembolic Disease in Patients Living With HIV

Like all illnesses related to the heart and blood, recommendations for preventing thromboembolic disease include general measures for promoting good cardiac health such as:

-Regular aerobic exercise several times a week
-Avoid sitting for long periods of time
-Maintain a healthy weight
-Don't use tobacco products

Treatment of Thromboembolic Disease in People Living With HIV

Thromboembolic disease is usually treated with medication, mechanical devices or a combination of the two. Mechanical methods of treatment include wearing graduated compression stockings and using manual compression devices to promote blood flow and prevent stasis.

Oral anticoagulants can be highly effective at treating thromboembolic disease, but doctors should use extreme caution when prescribing anticoagulants to patients with HIV because of potential interactions with antiretroviral medications. So far, nine cases of adverse interactions between anticoagulants and antiretrovirals have been documented. Documented drug interactions involving antiretrovirals can be found at http://www.hiv-druginteractions.org/Interactions.aspx. Even if no interaction is suspected, patients should be regularly monitored while combining treatments.

In very rare cases, surgery may be recommended to remove a blood clot; however, surgery increases the risk of developing future blood clots, so surgery is normally reserved for immediately life threatening circumstances.

References

http://myhivclinic.org/thromboembolic-disease
http://www.ncbi.nlm.nih.gov/pubmed/20825798
http://www.ncbi.nlm.nih.gov/pubmed/18828233
http://www.thrombosisadviser.com/en/vte-prevention/other-options-for-vte-prevention/

Top Selling Products